
chronicA
myelogenousA
leukemiaN
evolveV
inP
twoNUM
clinicallyR
distinctA
stageN
:PCT
aDT
chronicN
andCC
blastN
crisisN
phaseN
.PCT
theDT
molecularA
changeN
associateV
withP
toP
blastV
transitionN
beV
largelyR
unknownA
wePP
haveV
identifyV
cdnaN
cloneN
,PCT
dr-nm23N
differentiallyR
expressV
blast-crisisN
libraryN
whichDT
approximatelyR
@card@NUM
%N
sequenceN
similarityN
putativeA
metastaticA
suppressorN
geneN
nm23-h1A
nm23-h2A
deduceV
aminoN
acidN
proteinN
encodeV
byP
theseDT
latterA
includeV
domainN
residueN
(PCT
leucineN
zipper-likeA
rgdA
serineN
histidineN
nh2-N
cooh-terminalA
portionN
ofP
respectivelyR
)PCT
postulateV
importantA
forP
nm23A
functionN
dr-nm23A
mrnaN
preferentiallyR
atP
earlyA
myeloidA
differentiationN
highlyR
purifyV
cd34+A
cellN
itsPP
constitutiveA
expressionN
precursorN
32dc13A
lineN
growth-factorN
dependentA
bothDT
proliferationN
resultN
inhibitionN
granulocyticA
induceV
granulocyteN
colony-stimulatingN
factorN
causeV
apoptoticA
deathN
consistentA
roleN
normalA
hematopoiesiN
raiseV
possibilityN
thatP
overexpressionN
contributeV
arrestN
featureN
blasticA
transformationN
anDT
interferon-gammaN
activationN
mediateV
transcriptionalA
regulationN
iggN
fcN
receptorN
typeN
icN
iN
gammaN
riN
onP
dramaticallyR
increaseV
treatmentN
ifn-gammaN
observeV
transcriptN
levelN
monoblast-likeA
u937A
elevatedA
withinP
3NUM
hrN
peakV
afterP
exposureN
9NUM
presenceN
cycloheximideN
leadV
super-inductionN
nuclearA
run-onN
analysisN
revealV
rateN
transcriptionN
genomicA
upstreamR
ricA
clonV
subjectV
primeA
extensionN
demonstrateV
singleA
initiationN
siteN
withoutP
tataN
boxN
transientA
transfectionsN
catN
reporterN
constructV
containV
variousA
promoterN
intoP
20-bpA
regionN
surroundV
startN
+13N
capableA
responsiveA
elementN
gireN
presentA
bpN
17-bpA
betweenP
positionN
conferV
responsivenessN
heterologousA
double-strandedA
butCC
notR
scrambledA
specificallyR
bindV
fromP
treatV
gelN
shiftN
experimentN
furtherR
showV
stat1A
alphaN
responseN
homologousA
gasN
guanylateN
xPCT
classN
iiN
mhcN
ourPP
involveV
bindingA
homologyN
proximalA
constitutivelyR
activateV
jak-statN
pathwayN
tN
transformV
htlv-iN
humanA
lymphotropicA
virusN
etiologicalA
agentN
adultN
tropicalA
spasticA
paraparesisN
alsoR
termV
htlv-i-associatedA
myelopathyN
htlv-i-infectedA
peripheralA
bloodN
exhibitV
initialA
interleukin-2N
il-2A
-dependentA
growthN
;PCT
overP
timeN
mechanismN
becomeV
il-2-independentN
whereasP
jakN
kinaseN
jak1A
jak3A
signalN
transducerN
activatorN
stat3N
stat5N
il-2N
thisDT
signalV
htlv-i-transformedA
cordN
lymphocyteN
il-2-dependentN
il-2-independentA
correlateV
acquisitionN
suggestV
participateV
htlv-i-mediatedA
nitricA
oxideN
decreaseV
cytokine-inducedA
endothelialA
selectivelyR
reduceV
adhesionN
moleculeN
proinflammatoryA
cytokinesN
testV
hypothesisN
noUH
limitV
cytokine-stimulatedA
saphenousA
veinN
severalA
noDT
donorN
assessV
theirPP
effectN
inducibleA
vascularA
molecule-1N
vcam-1A
concentration-dependentA
mannerN
noR
inhibitV
interleukinN
ilN
alpha-stimulatedA
asP
determineV
surfaceN
enzymeN
immunoassayN
flowN
cytometryN
parallelV
monocyteN
monolayerN
nonstaticA
assayN
unaffectedA
cgmpN
analogueN
quantitativelyR
similarA
stimulationN
eitherDT
il-1A
betaN
il-4N
tumorN
necrosisN
tnfN
orCC
bacterialA
lipopolysaccharideN
otherA
leukocyteN
e-selectinN
lesserA
extentN
intercellularA
secretableA
il-6N
il-8N
endogenousA
productionN
l-n-monomethyl-arginineN
doV
augmentV
transfectionN
studyN
useV
constructN
electrophoreticA
mobilityN
indicateV
repressV
partN
nf-kappaN
bPCT
proposeV
abilityN
mayV
someDT
antiatherogenicA
antiinflammatoryA
propertyN
vesselN
wallN
mip1A
mnpN
novelA
hematopoieticA
thatDT
crucialA
mip-1A
murineA
macrophageN
inflammatoryA
1NUM
equivalentN
gos19N
ld78N
at464N
memberN
-c-cN
familyN
low-molecular-weightA
chemokinesN
secreteV
boneN
marrow-derivedV
alpha/N
primitiveA
stemN
appearV
homeostaticA
controlN
itPP
chemotaxisN
matureA
thereforeR
understandV
controlV
alpha/A
previousA
workN
jurkatN
setN
widelyR
ick-1A
affectV
gos19A
oneNUM
ick-1aN
behaveV
strongA
negativeA
regulatorN
communicationN
provideV
evidenceN
inductionN
differentA
furthermoreR
additionalA
overlapV
interactionN
extractV
tissueN
formationN
fast-migratingV
protein-dnaN
complexN
mutationN
abrogateV
inactivateV
gos19.1A
activityN
fourfoldA
SN
constituteV
toremifeneN
mononuclearA
exertV
multipleA
variedA
short-termA
vitroN
therapeuticalA
p-glycoproteinN
steroidN
p53N
bcl-2A
takeV
placeN
viewN
useN
antiestrogensN
cancerN
therapyN
preventionN
thereP
obviousA
meritN
long-termA
vivoA
conductV
interleukin-5/A
lynN
jak2A
tyrosineN
propagateV
viaP
ras-raf-1-mapN
eosinophilN
minN
il-5N
stimulateV
gtpN
p21rasN
subsequentlyR
throughP
raf-1N
mekN
mapN
asR
autophosphorylationN
phosphorylationN
situN
phosphorylateA
statN
studyV
probeN
findV
gas-bindingA
concludeV
1PCT
--PCT
&gtN
rasN
2PCT
jak2N
retinoblastomaN
productN
negativelyR
regulateV
cytomegalovirusN
ie2N
ie2A
hcmvN
fewA
viralA
regulatoryA
immediatelyR
uponP
infectionN
hostN
potentA
manyA
cellularA
susceptibilityN
RbN
suppressV
transactivationN
howeverR
unlikeP
anotherDT
anyDT
significantA
basalA
interactV
ratherR
thanP
generalA
machineryN
protein-affinityN
chromatographyN
produceV
translationN
directlyR
lifeN
cycleN
endemicA
populationN
datumN
newA
insightN
slowA
dnaN
replicationN
possibleA
involvementN
tumorigenesisN
nucleosideN
diphosphateN
skinN
immunohistochemicalA
ndpN
varietyN
specieN
inverselyR
potentialN
relationshipN
remainV
controversialA
accordV
experimentalA
systemN
conflictingA
researchN
groupN
orderN
whetherP
serveV
markerN
keratoacanthomasN
kasN
squamousA
carcinomaN
sccsN
bccsN
immunohistochemistryN
intenseA
kaN
sccN
compareV
bccN
differenceN
statisticallyR
metastasisN
contradictV
concernV
biologicalA
significanceN
cutaneousA
carcinogenesisN
e2f-1A
deficientA
B-cellN
transactivatorN
ciitaN
non-inducibleA
rb-defectiveA
majorA
histocompatibilityN
proteinV
bindN
antigenicA
peptideN
presentationN
T-cellN
b-cellsN
ebv-N
wideA
repressorN
e2f-iN
veryR
weaklyR
2NUM
vectorN
re-establishV
substantiallyR
enhanceV
inducibilityN
examineV
statusN
seriesN
mutantN
defectiveA
generateV
eitherR
deriveV
bareA
syndromeN
blsN
patientN
matrix-boundA
detectableA
allDT
caseN
lossN
responsibleA
secondA
mostR
likelyA
dp-iN
apparentlyR
ii-positiveN
-negativeA
knowV
formN
requireV
normallyR
re-expressionN
thusR
blockN
dueA
stat4N
il-12N
immunoregulatoryN
cytokineN
whosePP
hematopoietinN
superfamilyN
recentlyR
naturalA
killerN
janusN
tyk2N
implicateV
immediateA
biochemicalA
phosphorylatedA
numberN
reportN
stat4A
dna-bindingN
recognizeV
previouslyR
recentA
demonstrationN
rapidA
signal-transductionN
il-12-inducedA
temperature-inducedA
down-regulationN
glucocorticoidA
leucocyteN
sepsisN
septicA
shockN
objectiveN
hypothalamic-pituitary-adrenalA
axisN
vitalA
importanceN
duringP
criticalA
illnessN
adaptiveA
occurV
targetN
designN
hypercortisolaemiaN
hyperthermiaN
compositionN
perP
affinityN
evaluateV
bothCC
vivoR
subjectN
fifteenNUM
ageN
whoPP
admitV
intensiveA
careN
unitN
consistV
healthyA
laboratoryN
employeeN
measurementN
capacityN
glucocN
orticoidN
measureV
clinicalA
plasmaN
cortisolN
concentrationN
resultV
VitroN
wellR
variationN
influenceV
weakA
correlationN
bodyN
temperatureN
patientA
relationN
circulateV
conclusionN
togetherR
accompanyV
adaptationN
integrin-mediatedA
messageN
monocyticA
sykN
cytoplasmicA
aspectN
transductionN
integrinsN
thp-1N
eitherCC
integrin-dependentA
fibronectinN
ligationN
betaA
antibodyN
aboutR
kdaN
additionN
integrinN
translocationN
p50N
p65A
subunitsN
driveV
mrnasN
immediate-earlyA
inhibitorN
genisteinN
herbimycinN
increaseN
causalA
eventN
componentN
phosphorylatedV
subsequentA
paxillinN
pp125fakN
sh2A
contrastN
fakN
adhereV
pre-treatmentN
cytochalasinN
dPCT
whileP
observationN
dexamethasoneN
worldN
primateN
ifP
GrN
characteristicN
[PCT
3h]dexamethasoneA
cytosolN
prepareV
b95-8A
lymphoidA
cottonN
topA
tamarinN
saguinusN
oedipusN
combinationN
ratN
specificA
pN
&ltN
whenR
mixedA
hlN
thymusN
inhibitoryA
heatN
labileA
trypsinN
sensitiveA
peakA
kdN
fractionN
sephacrylN
g-200N
ultrafiltrationN
scatchardA
diminishedA
apparentA
kineticA
dissociationN
competitiveA
preventV
cognateA
disruptionN
gataN
motifN
duffyA
abolishV
erythroidA
duffy-negativeA
individualN
antigenN
erythrocyteN
plasmodiumN
vivaxN
malariaN
parasiteN
chemokineN
hereR
antigen/A
darcN
composeV
exonN
blackN
carryV
silentA
fy@star@bN
alleleN
cPCT
substitutionN
nucleotideN
impairV
disruptV
gata1A
characterizationN
fy@star@aN
findingN
basisN
explanationN
erythroid-specificA
repressionN
pp90rskN
response-1A
pokeweedN
mitogenN
humanN
pwmN
egr-1A
post-transcriptionalA
fragmentN
linkV
chloramphenicolN
acetyltransferaseN
cargN
c[at]6ggN
s6A
evidenceV
s6N
serumN
srfN
ableA
initiateV
intracytoplasmicA
cascadeN
conserveV
th2-typeN
novelN
t-cell-expressedA
mouseN
granulocyte/N
macrophage-colonyN
gm-csfN
]PCT
coreA
cttggN
...PCT
ccaagN
largeA
palindromicA
eachDT
theyPP
trans-actingV
positiveA
j6N
canV
giveV
sixNUM
bandN
competeV
outP
invertedA
repeatN
dependV
reconstitutionN
conditionN
separateV
integerN
helicalA
turnN
considerV
coordinateV
helperN
ngfi-b/A
nur77-relatedA
peerN
dieV
apoptosisN
pmaN
calciumN
ionophoreN
tinurN
hN
cross-linkingN
agN
belongV
nur77A
orphanN
sameA
ngfi-b/N
classifyV
subtypeN
aspirinN
factor-kappaN
mobilizationN
backgroundN
factor-alphaN
sinceP
salicylateN
reportV
degradationN
kappaN
potentialA
acetylsalicylateA
umbilicalA
huvecsN
methodN
gel-shiftN
dose-dependentA
tnf-inducedA
rangeV
mmol/N
lN
dose-dependentlyR
rangeN
icam-1A
hardlyR
functionalA
consequenceN
tnf-stimulatedA
markedlyR
suppressionN
upregulationN
relateV
cyclooxygenaseN
indomethacinN
ineffectiveA
therebyR
therapeuticA
phosphataseN
2a-sensitiveA
stimulusN
althoughP
underlieV
unclearA
serine/A
threonineN
investigateV
incubationN
lowA
nmN
calyculinN
okadaicA
pp-1N
2aN
pp-2aN
evenR
absenceN
actionN
relaN
p50A
heterodimerN
blockV
tnf-alphaN
a-treatedA
tnf-alpha-stimulatedA
existenceN
fundamentalA
inducerN
tnf-alpha-N
a-inducedA
identicalA
sensitivityN
proteasomeA
tnf-alpha-inducibleN
pp-2a-opposingN
targetV
proteasome-mediatedA
sp1A
chromatin-dependentA
alpha-globinN
5NUM
'PP
flankV
gN
+PCT
richA
copyN
consensusN
c-richN
far-upstreamN
enhancerN
hs-40N
transientlyR
transfectedA
deletionN
alpha-globinA
stableA
integrationN
chromatinN
nearlyR
decreaseN
retainV
finallyR
footprintN
stablyR
integratedA
sp1N
costimulationN
cd4+A
lfa-3N
b7A
ap-1N
earlierR
seaN
presentV
ChineseA
hamsterN
ovaryN
choN
-drN
transfectantsN
coexpressingV
profileN
nowR
lfa-3A
stronglyR
costimulatedA
maximalA
recordV
cho-dr/A
b7/A
cooperativeA
cho-drN
staphylococcalA
enterotoxinN
sufficientA
amountN
ap-1A
moderateA
enhancedA
lfa-3tripleN
transfectantN
furtherA
doubleA
oct-1A
sampleN
super-shiftN
complexA
substantialA
p65N
marginalA
c-relN
c-junN
jun-dN
fra-1A
jun-bN
c-fosN
partlyR
accountV
differentialA
ahN
theN
bsapN
dioxin-mediatedA
alterationN
cd19A
2,3,7,8-tetrachlorodibenzo-p-dioxinN
tcddN
murineN
immunoglobulinN
northernA
blotN
steadyA
stateN
im-9A
dna-bindingA
criterionN
bN
lineage-specificA
cd19N
ahrN
couldV
interfereV
bsap-stimulatedA
competitionN
commonA
i-factorN
m1A
homologN
